V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190002242 | 190000338 | 1.73 | 86.2 | Palliative (P) | 2016-10-27 | 2016-11-01 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | N | N | GEMCITABINE | 100383732 |
| 190002282 | 190000343 | 1.63 | 92.95 | Curative (C) | 2017-07-01 | 2017-07-02 | CARBOPLATIN + ETOPOSIDE | 02 | N | CARBOPLATIN + ETOPOSIDE | 100930579 |
| 190002287 | 190000344 | 1.67 | 57 | Palliative (P) | 2018-09-01 | 2018-09-01 | CISPLATIN + RT | 02 | N | FLUOROURACIL | 100688613 |
| 190002307 | 190000346 | null | null | null | null | 2016-10-02 | Oxaliplatin + Modified de Gramont | null | null | CAPECITABINE + CISPLATIN | 101559131 |
| 190002329 | 190000349 | null | null | null | null | 2017-02-23 | ECX | null | null | GEMCITABINE | 100957859 |
| 190002339 | 190000351 | null | null | null | null | 2016-09-07 | PAM x 2 post-surgery (cycles 3&4) | null | null | DOXORUBICIN + ETOPOSIDE + IFOSFAMIDE + VINCRISTINE | 101433339 |
| 190002354 | 190000354 | null | null | null | null | 2019-08-20 | OST Euramos 1 Closed Trial - Ai | null | null | CETUXIMAB | 101104792 |
| 190002376 | 190000357 | 1.87 | 91 | Palliative (P) | 2016-07-16 | 2016-07-30 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 100178403 |
| 190002416 | 190000361 | 1.8 | 67.8 | Curative (C) | 2016-07-25 | 2016-08-19 | LANREOTIDE | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101720813 |
| 190002427 | 190000362 | 1.66 | 71 | Curative (C) | 2019-07-28 | 2019-08-03 | Cisplatin+Gemcitabine (gallbladder) | 02 | null | CISPLATIN + GEMCITABINE | 100672376 |
| 190002434 | 190000364 | 0 | 43 | Curative (C) | 2017-09-16 | 2017-09-20 | FLUOROURACIL + OXALIPLATIN | N | null | DOCETAXEL + GEMCITABINE | 101630081 |
| 190002435 | 190000365 | null | null | null | null | 2016-09-13 | EW EuroEwing 2012 Arm A VIDE | null | null | CAPE + CARBOPLATIN + CETUXIMAB | 100964575 |
| 190002455 | 190000369 | 1.83 | 81 | Palliative (P) | 2017-05-01 | 2017-05-07 | Dox + HD Mtx (post PAM) | 02 | N | GEMCARBO | 101857095 |
| 190002476 | 190000370 | 1.79 | 52 | Palliative (P) | 2017-01-22 | 2017-01-27 | null | 02 | N | CISPLATIN + FLUOROURACIL + RT | 101182766 |
| 190002489 | 190000371 | 1.68 | 75 | Curative (C) | 2019-02-13 | 2019-03-21 | OCTREOTIDE | 02 | Y | LANREOTIDE | 100020685 |
| 190002520 | 190000374 | null | null | null | null | 2019-11-10 | Cisplatin + Etoposide po&iv 3 day | null | null | CISPLATIN + ETOPOSIDE | 100427851 |
| 190002563 | 190000377 | 1.62 | 28.4 | Adjuvant (A) | 2019-09-16 | 2019-09-23 | EW EuroEwing 2012 Arm B VDC | 02 | N | GC INT GUIDE EXCRANIAL GERMCELL JEB | 101540599 |
| 190002579 | 190000378 | 1.81 | 69.6 | Palliative (P) | 2018-05-06 | 2018-05-06 | Oxaliplatin + Modified de Gramont | 01 | N | BLEOMYCIN + CISPLATIN + ETOPOSIDE | 100055730 |
| 190002586 | 190000379 | null | null | null | null | 2018-12-23 | CARBOPLATIN + ETOPOSIDE | null | null | CARBOPLATIN + ETOPOSIDE | 100156959 |
| 190002601 | 190000381 | null | null | null | null | 2019-10-05 | Trial Unspecified | null | null | OCTREOTIDE | 100679277 |
| 190002610 | 190000384 | 0 | 19.3 | Palliative (P) | 2016-10-23 | 2016-10-27 | GemCarbo Days 1+8 | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100056091 |
| 190002634 | 190000386 | null | null | null | null | 2019-03-25 | PAM | null | null | ECX | 100109230 |
| 190002642 | 190000389 | 0 | 57.4 | Adjuvant (A) | 2017-01-08 | 2017-01-14 | CARBOPLATIN + ETOPOSIDE | 02 | N | LANREOTIDE | 100852773 |
| 190002655 | 190000391 | null | 65.3 | Palliative (P) | 2018-09-28 | 2018-10-03 | OST Euramos 1 Closed Trial - AP | 02 | null | DOXORUBICIN + OLARATUMAB | 100264313 |
| 190002676 | 190000393 | 1.76 | 85.8 | Palliative (P) | 2017-05-25 | 2017-05-30 | Dox + HD Mtx (post PAM) | 01 | null | CETUXIMAB + CISPLATIN + FLUOROURACIL | 100618413 |
| 190002681 | 190000395 | 1.83 | 132 | Curative (C) | 2016-09-17 | 2016-09-18 | FEC 100 | 02 | N | OXALIPLATIN + MDG | 100273167 |
| 190002687 | 190000397 | null | null | null | null | 2018-10-31 | EURAMOS TRIAL | null | null | CISPLATIN + FLUOROURACIL | 101846924 |
| 190002699 | 190000399 | null | null | null | null | 2018-03-12 | Capecitabine | null | null | CARBOPLATIN + GEMCITABINE | 101208849 |
| 190002717 | 190000402 | 1.57 | 54.7 | Palliative (P) | 2018-01-28 | 2018-01-28 | Carboplatin + Etoposide IV 3 day | 02 | N | CARBOPLATIN + ETOPOSIDE | 100249633 |
| 190002733 | 190000405 | 1.69 | 61.5 | Palliative (P) | 2016-09-03 | 2016-09-03 | CARBOPLATIN + PACLITAXEL | 02 | N | CARBOPLATIN + PACLITAXEL | 100895752 |
| 190002745 | 190000406 | 1.87 | 77.4 | Palliative (P) | 2018-12-27 | 2019-01-04 | CARBOPLATIN | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100443925 |
| 190002750 | 190000407 | null | null | null | null | 2016-05-06 | CARBOPLATIN + ETOPOSIDE | null | null | CARBOPLATIN + ETOPOSIDE | 101620716 |
| 190002753 | 190000408 | null | null | null | null | 2018-03-27 | EW EuroEwing 2012 Arm B VDC | null | null | EOX | 100530975 |
| 190002765 | 190000410 | 1.83 | 78.2 | null | null | 2018-01-11 | CARBOPLATIN + RT | null | null | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 101785395 |
| 190002775 | 190000413 | 1.59 | 66.35 | null | 2017-12-21 | 2017-12-26 | NB Low/Interm risk guidelines Carbo/Etop | 2 | null | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101202345 |
| 190002782 | 190000414 | 1.59 | 69.8 | Palliative (P) | 2017-10-03 | 2017-10-04 | CARBOPLATIN + RT | 02 | N | CISPLATIN + DOXORUBICIN | 101448510 |
| 190002815 | 190000418 | 1.73 | 37 | Palliative (P) | 2017-08-18 | 2017-09-12 | CISPLATIN + ETOPOSIDE | 02 | N | METHOTREXATE + VINBLASTINE | 100922463 |
| 190002817 | 190000419 | 1.75 | 83.4 | Palliative (P) | 2019-01-14 | 2019-01-14 | Cisplatin | 02 | N | CISPLATIN | 101603047 |
| 190002826 | 190000422 | null | null | null | null | 2017-02-10 | Palbociclib | null | null | CARBOPLATIN + VINORELBINE | 100518843 |
| 190002827 | 190000423 | 0 | 97.6 | Neo-adjuvant (N) | 2016-09-16 | 2016-09-27 | Trial Unspecified | 02 | N | LANREOTIDE | 100809088 |
| 190002840 | 190000426 | null | null | null | null | 2017-06-05 | Oxaliplatin + Modified de Gramont | null | null | CAPECITABINE + TEMOZOLOMIDE | 100665051 |
| 190002845 | 190000428 | 0 | 28.6 | Palliative (P) | 2017-02-08 | 2017-02-15 | Carboplatin + Paclitaxel (3 weekly) | N | N | CARBOPLATIN + PACLITAXEL | 100814648 |
| 190002852 | 190000430 | 1.65 | 97.8 | Palliative (P) | 2016-06-11 | 2016-07-04 | Carboplatin + Etoposide iv&po | null | null | CARBOPLATIN + ETOPOSIDE | 100877818 |
| 190002857 | 190000432 | null | null | null | null | 2020-01-12 | Cisplatin + Radiotherapy | null | null | CISPLATIN | 101667982 |
| 190002874 | 190000435 | null | null | null | null | 2016-04-19 | LU-177 | null | null | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 100263619 |
| 190002888 | 190000436 | 1.7 | 72.5 | Curative (C) | 2016-09-17 | 2016-10-01 | Dox + HD Mtx (post PAM) | N | N | EVEROLIMUS | 101113848 |
| 190002897 | 190000437 | 1.8 | 57 | Neo-adjuvant (N) | 2018-08-01 | 2018-08-01 | Cisplatin 7 day | 02 | null | CISPLATIN | 100216893 |
| 190002899 | 190000438 | null | null | null | null | 2019-08-19 | EW EuroEwing 99 : VIDE | null | null | GEMCITABINE | 101695104 |
| 190002904 | 190000439 | null | null | null | null | 2018-12-21 | ECX | null | null | CAPECITABINE | 101654236 |
| 190002918 | 190000441 | 1.72 | 83.6 | Curative (C) | 2016-09-24 | 2016-09-24 | OCTREOTIDE | 02 | N | OCTREOTIDE | 101038140 |